Nuvectis Pharma Inc (NVCT)
Healthcare
Biotechnology
21.60 $
+0.4%
vs. previous close
Closing price · As of: 3. Aug 2026
Nuvectis Pharma Inc (NVCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -6.5 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -4.1 | -3.2 | -3.9 | -4.4 | -3.0 | -2.4 | -2.5 | -4.2 | -3.4 | -4.5 | -4.0 | -6.5 | -18 | |
| 1.0 | 1.1 | 1.2 | 1.3 | 1.3 | 1.2 | 1.1 | 1.4 | 1.7 | 1.5 | 1.5 | -0.5 | 4.2 | |
| 1.0 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.7 | 1.5 | 1.6 | -1.5 | 0.1 | 0.6 | 2.6 | -0.2 | 1.2 | 1.5 | 1.9 | -2.3 | 2.3 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 14 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 13 | 0.7 | 0.9 | 4.7 | 1.7 | 1.5 | 3.8 | 16 | 0.3 | 13 | 0.2 | 0.0 | 14 | |
| 9.1 | -2.5 | -2.9 | 0.3 | -1.3 | -0.9 | 1.4 | 11 | -3.1 | 8.6 | -3.8 | -6.5 | -4.7 | |
| -4.1 | -3.2 | -3.9 | -4.4 | -3.0 | -2.4 | -2.5 | -4.2 | -3.4 | -4.5 | -4.0 | -6.5 | -18 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.